NCT00028028View on ClinicalTrials.gov

CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 28, 2002

Primary Completion Date

January 31, 2007

Conditions
Extensive Stage Small Cell Lung Cancer
Interventions
DRUG

temsirolimus

Given IV

OTHER

pharmacological study

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

Trial Locations (1)

02215

Eastern Cooperative Oncology Group, Boston

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00028028 - CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter